Northern Ireland Chest Heart & Stroke Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2008
NCT01219036
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Northern Ireland Chest Heart and Stroke

Active Ingredients

Drugs in Other Trials (2)

budesonide (rhinocort) (1 trial)

fkbp51 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2